Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3
From the *Department of Molecular Sciences and the ‡Department of Immunology, Central Research Division, Pfizer Inc., Groton, Connecticut 06340; and the §Theodor Kocher Institute, University of Bern, CH-300-ern-9, Switzerland